You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Harvard Business School
Merck
McKinsey

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 10,519,228

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,519,228
Title:Methods for reducing drug-induced liver injury
Abstract: The present disclosure provides methods of treating a patient with infliximab or alternative therapies to reduce the risk of developing, and/or severity of, an adverse drug reaction such as drug-induced liver injury. The methods include identifying patients at risk for developing DILI by determining the presence or absence of one or more HLA alleles in the patients.
Inventor(s): Srinivasan; Sundar (Corona Del Mar, CA), Chow; Christina (Seattle, WA)
Assignee: TEN PEAKS LLC (Corona Del Mar, CA)
Application Number:16/406,700
Patent Claims:see list of patent claims

Details for Patent 10,519,228

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial TEN PEAKS LLC (Corona Del Mar, CA) 2038-05-08 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial TEN PEAKS LLC (Corona Del Mar, CA) 2038-05-08 RX Orphan search
Janssen Biotech STELARA ustekinumab INJECTABLE;INJECTION 761044 001 2019-11-07   Start Trial TEN PEAKS LLC (Corona Del Mar, CA) 2038-05-08 RX search
Sanofi Synthelabo KEVZARA sarilumab INJECTABLE;INJECTION 761037 002 2018-04-13   Start Trial TEN PEAKS LLC (Corona Del Mar, CA) 2038-05-08 RX search
Sanofi Synthelabo KEVZARA sarilumab INJECTABLE;INJECTION 761037 001 2018-04-13   Start Trial TEN PEAKS LLC (Corona Del Mar, CA) 2038-05-08 RX search
Eli Lilly And Co TALTZ ixekizumab INJECTABLE;INJECTION 125521 001 2016-03-22   Start Trial TEN PEAKS LLC (Corona Del Mar, CA) 2038-05-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Moodys
Harvard Business School
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.